Soleus Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.2M Buy
1,931,436
+1,355,137
+235% +$64.3M 2.97% 7
2026
Q1
$29.7M Buy
576,299
+276,900
+92% +$19.4M 1.2% 24
2025
Q4
$27.6M Sell
299,399
-428,789
-59% -$41M 1.02% 28
2025
Q3
$54M Buy
728,188
+619,188
+568% +$62.7M 2.72% 10
2025
Q2
$14.1M Buy
109,000
+70,000
+179% +$10.2M 0.94% 31
2025
Q1
$6.21M Buy
+39,000
New +$7.06M 0.45% 48
2023
Q4
Sell
-35,600
Closed -$7.06M 90
2023
Q3
$7.06M Buy
35,600
+28,900
+431% +$7.29M 0.65% 44
2023
Q2
$2.18M Sell
6,700
-8,900
-57% -$2.54M 0.24% 74
2023
Q1
$3.65M Sell
15,600
-30,600
-66% -$7.74M 0.38% 57
2022
Q4
$11.6M Sell
46,200
-21,200
-31% -$4.52M 1.67% 23
2022
Q3
$12M Sell
67,400
-21,550
-24% -$4.33M 1.62% 21
2022
Q2
$16.2M Buy
88,950
+41,050
+86% +$8.19M 2.53% 11
2022
Q1
$12.3M Buy
47,900
+20,450
+74% +$4.67M 1.59% 25
2021
Q4
$6.32M Sell
27,450
-3,500
-11% -$855K 0.63% 33
2021
Q3
$7.21M Buy
30,950
+9,400
+44% +$1.96M 1.12% 28
2021
Q2
$4.17M Buy
+21,550
New +$4.27M 0.64% 32
2020
Q3
Sell
-5,608
Closed -$488K 68
2020
Q2
$488K Buy
+5,608
New +$431K 0.28% 56
2020
Q1
Sell
-9,008
Closed -$668K 57
2019
Q4
$668K Buy
+9,008
New +$579K 0.64% 35

Other funds holding INSP

Soleus Capital Management's INSP Position: Q2 2026 in Review

Soleus Capital Management increased its Inspire Medical Systems (INSP) stake by 235% in Q2 2026, buying an estimated $64.3M and bringing the position to 1,931,436 shares worth $86.2M. The position accounts for 2.97% of the portfolio, ranked #7.

Soleus Capital Management first reported a position in INSP in Q4 2019 and has held it in 18 quarters since. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Soleus Capital Management held 1,931,436 shares of Inspire Medical Systems worth $86.2M as of Q2 2026.
  • Soleus Capital Management bought 1,355,137 Inspire Medical Systems shares in Q2 2026, an estimated $64.3M.
  • Inspire Medical Systems made up 2.97% of Soleus Capital Management's portfolio in Q2 2026, its #7 holding.
  • Soleus Capital Management first reported a position in Inspire Medical Systems in Q4 2019 and has held it in 18 quarters since.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.